Hey Coads. Thanks for posting that quote again. I thought about this after the presso. Seems we've wound down working capital expenditure due to the trial winding up anyway. (Speculation)
We'll likely see this through until another trial starts, hopefully with OPM (other people's money)
Tissue Engineering v. Immunotherapy, page-19
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.20 |
Change
0.200(1.11%) |
Mkt cap ! $349.8M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.20 | $17.65 | $78.15K | 4.366K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 619 | $17.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.20 | 146 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |